Diabetes medicine decreases cardiovascular risk in adults with chronic kidney disease
Medical Xpress
NOVEMBER 7, 2022
SGLT-2 inhibitors, a type of diabetes medicine, decreased cardiovascular risk among adults with chronic kidney disease, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2022. The meeting, held in person in Chicago and virtually, Nov.
Let's personalize your content